A Season of Gratitude: Why My Family Supports LuMind IDSC
Thirty years ago, our family plans changed when our first child, Gwendolyn, was born with Down syndrome. Over time, we realized life would be different, but just as rewarding – […]
Angie Del Gaudio Awarded Collin Lis Humanitarian Award
Angie Del Gaudio from Long Beach, CA has been selected as the 2024 Collin Lis Humanitarian Award winner. Del Gaudio created the “Rams Without Limits” after-school dance program for neurodiverse […]
RAND report shows benefit of investment in future health outcomes for adults with Down syndrome
10/1/2024 | For immediate release | Contact: Kate O’Neill ([email protected]) Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome, New Report […]
His Amazing Self: a brother’s reflection on Down syndrome-associated Alzheimer’s Disease
My brother, Rohan, was born 38 years ago in the city of Bangalore in India. He was born with Down syndrome. When he was three years old, my parents made […]
Pathways to Parity Program Approved for $250K PCORI Engagement Award
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C. (Aug. 13, 2024) – The Alliance for Aging Research and […]
LuMind IDSC Presents the Collin Lis Humanitarian Award to Two Employees
In honor of Collin Lis, a kind and loving 11-year-old boy with Down syndrome, LuMind IDSC is presenting the Collin Lis Humanitarian Award to two members of the Down syndrome […]
FDA issues approval for new Alzheimer’s drug Kisunla; Down syndrome community is optimistic
FDA issues approval for Kisunla, new Alzheimer’s drug; Down syndrome community optimistic On Tuesday, July 2, the U.S. Food and Drug Administration (FDA) announced the approval of Kisunla (donanemab), an […]
Navigating the Road to Graduation for Students with Disabilities
Graduation from high school is a major accomplishment in the journey we each experience through life. According to the U.S. Department of Education’s National Center for Education Statistics, the overall […]
Down syndrome population will see a clinical trial of new Alzheimer’s drug
Major pharmaceutical company announces Down syndrome population will see a clinical trial of new Alzheimer’s drug People with Down syndrome will be invited to participate in a clinical trial of […]
Clinical Trials Day: A Historic Review of the First Clinical Trial
James Lind, a United Kingdom’s Royal Navy surgeon, is considered the “Father of Clinical Trials.” Each year, on May 20, we celebrate Clinical Trials Day and Lind’s contribution to the […]